Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280496856> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4280496856 endingPage "336" @default.
- W4280496856 startingPage "325" @default.
- W4280496856 abstract "Up to half of all patients with metastatic human epidermal growth factor receptor 2-positive (HER2+) breast cancer will eventually acquire brain metastases (BrMs), which are associated with reduced overall survival and decreased quality of life. Although the median overall survival was previously less than a year, novel systemic treatments have significantly extended life expectancy in patients with HER2+ breast cancer BrMs. The current first-line standard of care for all patients with HER2+ metastatic breast cancer, regardless of BrMs status, is dual HER2 antibody therapy with pertuzumab/trastuzumab plus a taxane. Second-line systemic therapy has recently evolved, with the option of trastuzumab deruxtecan (T-DXd) or tucatinib in combination with trastuzumab and capecitabine. T-DXd has shown dramatically superior progression-free survival in comparison with trastuzumab emtansine (T-DM1) in patients with stable BrMs in the second-line setting. Patients who have untreated or locally treated/progressive BrMs may benefit from a regimen with robust intracranial response rates, such as tucatinib in combination with trastuzumab and capecitabine. Third-line therapy and beyond includes multiple options that require careful selection, with the patient's BrMs status, comorbidities, and performance status taken into account. In this review, we focus on current management and evolving strategies for the treatment of patients with HER2+ breast cancer BrMs." @default.
- W4280496856 created "2022-05-22" @default.
- W4280496856 creator A5005079864 @default.
- W4280496856 creator A5013516632 @default.
- W4280496856 creator A5013557141 @default.
- W4280496856 creator A5062439120 @default.
- W4280496856 date "2022-05-01" @default.
- W4280496856 modified "2023-09-29" @default.
- W4280496856 title "Systemic management of brain metastases in HER2+ breast cancer in 2022." @default.
- W4280496856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35579591" @default.
- W4280496856 hasPublicationYear "2022" @default.
- W4280496856 type Work @default.
- W4280496856 citedByCount "0" @default.
- W4280496856 crossrefType "journal-article" @default.
- W4280496856 hasAuthorship W4280496856A5005079864 @default.
- W4280496856 hasAuthorship W4280496856A5013516632 @default.
- W4280496856 hasAuthorship W4280496856A5013557141 @default.
- W4280496856 hasAuthorship W4280496856A5062439120 @default.
- W4280496856 hasConcept C121608353 @default.
- W4280496856 hasConcept C126322002 @default.
- W4280496856 hasConcept C143998085 @default.
- W4280496856 hasConcept C2775930923 @default.
- W4280496856 hasConcept C2777511904 @default.
- W4280496856 hasConcept C2777909004 @default.
- W4280496856 hasConcept C2779786085 @default.
- W4280496856 hasConcept C2781164504 @default.
- W4280496856 hasConcept C526805850 @default.
- W4280496856 hasConcept C530470458 @default.
- W4280496856 hasConcept C71924100 @default.
- W4280496856 hasConceptScore W4280496856C121608353 @default.
- W4280496856 hasConceptScore W4280496856C126322002 @default.
- W4280496856 hasConceptScore W4280496856C143998085 @default.
- W4280496856 hasConceptScore W4280496856C2775930923 @default.
- W4280496856 hasConceptScore W4280496856C2777511904 @default.
- W4280496856 hasConceptScore W4280496856C2777909004 @default.
- W4280496856 hasConceptScore W4280496856C2779786085 @default.
- W4280496856 hasConceptScore W4280496856C2781164504 @default.
- W4280496856 hasConceptScore W4280496856C526805850 @default.
- W4280496856 hasConceptScore W4280496856C530470458 @default.
- W4280496856 hasConceptScore W4280496856C71924100 @default.
- W4280496856 hasIssue "5" @default.
- W4280496856 hasLocation W42804968561 @default.
- W4280496856 hasOpenAccess W4280496856 @default.
- W4280496856 hasPrimaryLocation W42804968561 @default.
- W4280496856 hasRelatedWork W1811689 @default.
- W4280496856 hasRelatedWork W2083469 @default.
- W4280496856 hasRelatedWork W2337926 @default.
- W4280496856 hasRelatedWork W2422317 @default.
- W4280496856 hasRelatedWork W250179 @default.
- W4280496856 hasRelatedWork W2976006 @default.
- W4280496856 hasRelatedWork W3819646 @default.
- W4280496856 hasRelatedWork W4741852 @default.
- W4280496856 hasRelatedWork W5038423 @default.
- W4280496856 hasRelatedWork W5387012 @default.
- W4280496856 hasVolume "20" @default.
- W4280496856 isParatext "false" @default.
- W4280496856 isRetracted "false" @default.
- W4280496856 workType "article" @default.